Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

WHY-AD Unravelling White Matter Biological Heterogeneity for the Prediction of AD

Coordinator
Universita Degli Studi Di Genova, Italy
Runs
1 November 2025 to 31 October 2027
Status
Running
EU funding
€194k
Total cost
—
Partners
2 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101204296

What the project is doing

In the project's own words, from its summary on CORDIS.

White matter (WM) is being increasingly studied in Alzheimer’s disease (AD) as a possible key pathological driver. In-vivo, WM health can be measured through several metrics derived from diffusion weighted imaging (DWI). While these metrics provide information about the WM micro- and macro-structural alterations, the biological processes determining such changes is often unclear. Characterizing these biological pathways is crucial for a more refined use of MRI in the clinics and for building accurate disease models for individualized prediction.

In this work, we will use several cohorts covering the AD spectrum with both available MRI and biological data (genetics, proteomics). We will first perform a characterization of the biological pathways that provoke WM dysfunction in different stages of AD. Subsequently, we will use this information to build data-driven models of disease progression and spreading. Finally, we will test the applicability of these models in data from memory clinics.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di GenovaGenovaItalyCoordinator
Irccs Azienda Ospedaliera MetropolitanaGenovaItalyAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI